LUMBY, BC, Sept. 29 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that they have changed media buyers. avVaa World Health Care Products, Inc. is no longer working with Koeppel Direct, and instead has reached an agreement with Synergixx to provide media buying services for avVaa's next Neuroskin Psoriasis Relief DRTV test run. "While our first DRTV test week received a positive response from viewers, we did not have the audience reach we were hoping for," stated Lorie Campbell-Farley, President and COO. "It became obvious that we needed to take a more holistic approach to our campaign and micromanage the details. Synergixx was able to offer us this management capability. With their guidance we were able to achieve greater reach and more than double the DRTV spots at the same cost as our first test." When avVaa began looking at other media buying options, Synergixx helped them interpret their results from the first test and evaluate new media options that were presented to them. They also worked to refine the telemarketing process based on what was learned from the first test. The result of this collaboration is an impressive 2 week DRTV test proposal. The proposal includes more than 100 DRTV spots over two weeks, and targets both national and regional TV stations that offer high subscriber rates with viewers that fit Neuroskin's target demographic. "When we began looking at other media buying options, Synergixx jumped in and gave us the insight we needed to get a huge bang for our buck," commented Mrs. Campbell-Farley. "They have worked with several other health and beauty products, so there knowledge help us to tailor the proposal to fit our needs." Synergixx has already proven themselves as a valuable resource on the call centre side. During the first test run, Synergixx closed more than half of all calls, and upsold 56% of buyers to a purchase of at least three bottles. "We look forward to working more closely with Synergixx," said Mrs. Campbell-Farley, "And we anticipate announcing our second DRTV media test dates within the next week." About avVaa World Health Care Products avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: http://www.avvaa.com/. Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition. DATASOURCE: avVaa World Health Care Products CONTACT: avVaa World Health Care Products, Jack Farley, Chairman/CEO, ; Lorie Campbell-Farley, President/COO, ; Investor Relations: Merle Goertz (West Coast), (604) 688-2349

Copyright